Diagnosis and Treatment of Helicobacter pylori


Virtual Lecture

Expires: January 19, 2024

Overview

In this month’s “Virtual Lecture,” Robin Patel, M.D., discusses a new, noninvasive approach to the diagnosis of Helicobacter pylori infection that also assesses antimicrobial resistance.

Presentation

Length of video: 36 minutes

Presenter

Image of Robin Patel, M.D. 800x800

Robin Patel, M.D.

Elizabeth P. and Robert E. Allen Professor of Individualized Medicine
Professor of Medicine and Microbiology
Vice Chair of Education
Division of Clinical Microbiology
Mayo Clinic, Rochester, Minnesota

Learning objectives

Upon completion of this activity, participants should be able to:

  • Define approaches to diagnosing Helicobacter pylori infection.
  • Understand the impact of antimicrobial resistance on treatment of H. pylori infection.
  • Discuss a new diagnostic test that simultaneously detects H. pylori and provides information about its antimicrobial resistance or susceptibility to clarithromycin.

Intended audience

This program is appropriate for clinicians, pathologists, medical technologists, nurses, pharmacists, and other allied health staff.

Credit

The following types of credit are offered for this event:

ASCLS P.A.C.E.®

Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of .5 P.A.C.E.® contact hour.

To obtain credit


1. Watch the video.

2. Complete the posttest and evaluation that launches immediately following the video.

3. Generate and print your certificate(s).

Level of instruction for this program is intermediate.

Faculty disclosure


Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.

Questions?

Contact us: mcleducation@mayo.edu

Photo credit

Shutterstock

MCL Education (@mmledu)

MCL Education

This post was developed by our Education and Technical Publications Team.